Locoid 0.1% ointment

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Hydrocortisone butyrate

Available from:

Neon Healthcare Ltd

ATC code:

D07AB02

INN (International Name):

Hydrocortisone butyrate

Dosage:

1mg/1gram

Pharmaceutical form:

Cutaneous ointment

Administration route:

Cutaneous

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 13040000; GTIN: 5013346026240 5013346026370

Patient Information leaflet

PACKAGE LEAFL ET: INFORMATION FOR THE USER
LOCOID
® OINTMENT
Hydrocortisone butyrate 0.1% w/w
READ ALL OF THIS LEAFL ET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leafl et. You may need to read it again.
•
If you have any further questions, ask your doctor, pharmacist or
nurse.
•
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as yours.
•
If you get any side eff ects, talk to your doctor, pharmacist or
nurse. This includes any possible side
eff ects not listed in this leafl et. See section 4.
WHAT IS IN THIS LEAFL ET:
1.
What Locoid Ointment is and what it is used for
2.
What you need to know before you use Locoid Ointment
3.
How to use Locoid Ointment
4.
Possible side eff ects
5.
How to store Locoid Ointment
6.
Contents of the pack and other information
1. WHAT LOCOID OINTMENT IS AND WHAT IT IS USED FOR
Locoid Ointment contains the active substance hydrocortisone butyrate.
This is a corticosteroid
which when made up as an ointment is for use on the skin. This is
known as topical application.
Topical corticosteroids are ranked as mildly potent, moderately
potent, potent and very potent; Locoid
Ointment is classed as potent. Topical corticosteroids are able to
reduce the infl ammation caused
by a variety of skin conditions, and so allow it to get better. They
can also aff ect the cause of the
condition, which can lead to its healing.
Locoid Ointment is indicated in adults, children and infants. It is
used to treat a variety of skin
conditions that respond to topical corticosteroids. Among these are
eczema and dermatitis (itching)
of all types including atopic (childhood) eczema, photodermatitis
(itching caused by exposure to light)
and dermatitis caused by skin irritants and allergies.
It can also be used in the treatment of psoriasis, a condition
resulting in thickening of areas of the
skin. It is important that you follow your doctor’s instruction

Summary of Product characteristics

OBJECT 1
LOCOID OINTMENT
Summary of Product Characteristics Updated 15-Sep-2016 | Leo
Laboratories Limited
1. Name of the medicinal product
Locoid Ointment
2. Qualitative and quantitative composition
Locoid Ointment contains 0.1% w/w hydrocortisone butyrate.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Ointment.
The product is a translucent, light grey to whitish, soft fatty
ointment.
4. Clinical particulars
4.1 Therapeutic indications
Locoid Ointment is indicated in adults, children and infants. The
product is recommended for clinical use
in the treatment of conditions responsive to topical corticosteroids
e.g. eczema, dermatitis and psoriasis.
Topical corticosteroids are not generally indicated in psoriasis but
may be acceptable in psoriasis
excluding widespread plaque psoriasis provided warnings are given, see
section 4.4 Special warnings and
precautions for use.
4.2 Posology and method of administration
Posology
_Adults and older people _
The same dose is used for adults and older people, as clinical
evidence would indicate that no special
dosage regimen is necessary in older people.
_Children_
Long term treatment should be avoided where possible.
_Infants _
Therapy should be limited if possible to a maximum of seven days.
Method of administration
For cutaneous use.
Dosage: To be applied evenly and sparingly no more than twice daily.
Application may be made under occlusion in the more resistant lesions
such as thickened psoriatic
plaques on elbows and knees.
4.3 Contraindications
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.
This preparation is contraindicated in the presence of untreated viral
or fungal infections, tubercular or
syphilitic lesions, peri-oral dermatitis, acne vulgaris and rosacea
and in bacterial infections unless used in
connection with appropriate chemotherapy.
4.4 Special warnings and precautions for use
Application under occlusion should be restricted to dermatoses
involving limited areas.
As with all corticosteroid